New directions in CNS drug delivery

Robert Langer; Henry Brem; Laura Feigenbaum Langer

doi:10.1016/0197-4580(89)90164-4

New directions in CNS drug delivery

Robert Langer, Henry Brem, Laura Feigenbaum Langer

School of Medicine

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

This commentary expands on the above article in 2 ways. First, it provides more recent information on polymer-based drug delivery systems. Second, it discusses experimental systems that may be clinically viable in the future such as prodrugs, cell-polymer transplants and gene transplants.

Original language	English (US)
Pages (from-to)	642-644
Number of pages	3
Journal	Neurobiology of Aging
Volume	10
Issue number	5
DOIs	https://doi.org/10.1016/0197-4580(89)90164-4
State	Published - Jan 1 1989

ASJC Scopus subject areas

Neuroscience(all)
Aging
Clinical Neurology
Developmental Biology
Geriatrics and Gerontology

Access to Document

10.1016/0197-4580(89)90164-4

Cite this

@article{06c2de947a3c45608da7349f3c808a56,

title = "New directions in CNS drug delivery",

abstract = "This commentary expands on the above article in 2 ways. First, it provides more recent information on polymer-based drug delivery systems. Second, it discusses experimental systems that may be clinically viable in the future such as prodrugs, cell-polymer transplants and gene transplants.",

author = "Robert Langer and Henry Brem and Langer, {Laura Feigenbaum}",

year = "1989",

month = jan,

day = "1",

doi = "10.1016/0197-4580(89)90164-4",

language = "English (US)",

volume = "10",

pages = "642--644",

journal = "Neurobiology of Aging",

issn = "0197-4580",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - New directions in CNS drug delivery

AU - Langer, Robert

AU - Brem, Henry

AU - Langer, Laura Feigenbaum

PY - 1989/1/1

Y1 - 1989/1/1

N2 - This commentary expands on the above article in 2 ways. First, it provides more recent information on polymer-based drug delivery systems. Second, it discusses experimental systems that may be clinically viable in the future such as prodrugs, cell-polymer transplants and gene transplants.

AB - This commentary expands on the above article in 2 ways. First, it provides more recent information on polymer-based drug delivery systems. Second, it discusses experimental systems that may be clinically viable in the future such as prodrugs, cell-polymer transplants and gene transplants.

UR - http://www.scopus.com/inward/record.url?scp=0024325926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024325926&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(89)90164-4

DO - 10.1016/0197-4580(89)90164-4

M3 - Article

C2 - 2812246

AN - SCOPUS:0024325926

SN - 0197-4580

VL - 10

SP - 642

EP - 644

JO - Neurobiology of Aging

JF - Neurobiology of Aging

IS - 5

ER -

New directions in CNS drug delivery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this